| Aktier | 585,25 Mrd | — | KO KoAct | 0,00 | Hälsovård | | 2023-08-03 | 21 596,80 | 8,05 | 37,04 |
TE | Aktier | 234,1 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 2020-10-07 | 6 300,55 | 6,03 | 51,44 |
KO | Aktier | 185,8 Mrd | — | KO KODEX | 0,45 | Hälsovård | FnGuide Bio Index - Benchmark TR Gross | 2016-05-13 | 7 036,83 | 5,44 | 37,93 |
TE | Aktier | 130,3 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KRX Healthcare - KRW | 2011-07-18 | 31 929,15 | 4,63 | 39,62 |
TE | Aktier | 103 Mrd | — | TE Tiger ETF | 0,30 | Hälsovård | NASDAQ / Biotechnology | 2014-08-27 | 33 895,64 | 4,88 | 21,01 |
| Aktier | 71,7 Mrd | — | KR KB RISE | 0,00 | Hälsovård | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 2024-12-24 | 15 679,68 | 9,56 | 68,04 |
KO | Aktier | 61,4 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Health Care Select Sector | 2023-03-21 | 13 619,17 | 4,86 | 22,50 |
KO | Aktier | 60,9 Mrd | — | KO KODEX | 0,09 | Hälsovård | KRX Healthcare - KRW | 2017-03-28 | 14 697,57 | 4,63 | 39,65 |
SP | Aktier | 46,92 Mrd | 9,34 M | SP SPDR | 0,08 | Hälsovård | S&P Health Care Select Sector | 1998-12-16 | 177,45 | 4,86 | 22,63 |
TE | Aktier | 44,5 Mrd | — | TE Tiger ETF | 0,45 | Hälsovård | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 2024-02-29 | 10 059,99 | 7,96 | 17,83 |
KO | Aktier | 42,66 Mrd | — | KO KODEX | 0,45 | Hälsovård | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 2024-02-14 | 10 794,98 | 5,08 | 12,43 |
TE | Aktier | 40,1 Mrd | — | TE Tiger ETF | 0,49 | Hälsovård | Solactive China Biotech Index | 2020-12-08 | 7 596,64 | 4,03 | 28,69 |
TE | Aktier | 39,2 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 2016-12-15 | 8 350,09 | 10,44 | 59,10 |
TE | Aktier | 32,2 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 2016-07-01 | 27 779,29 | 0,00 | 0,00 |
TE | Aktier | 29,3 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KOSPI 200 Health Care Index - KRW | 2015-09-23 | 19 257,40 | 2,91 | 30,55 |
| Aktier | 28,45 Mrd | — | HW Hwabao | 0,60 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2019-05-20 | 0,34 | 3,08 | 30,88 |
KO | Aktier | 21,9 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Biotechnology Select Industry | 2013-10-31 | 41 118,41 | 0,00 | 0,00 |
VA | etf_assetclass_Sector Equity | 20,8 Mrd | 235 508 | VA Vanguard | 0,09 | Hälsovård | MSCI US IMI 25/50 Health Care | 2004-01-26 | 327,91 | 5,01 | 23,09 |
EF | Aktier | 17,42 Mrd | — | EF E Fund | 0,00 | Hälsovård | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 2021-01-09 | 0,37 | 3,40 | 26,67 |
NH | Aktier | 16 Mrd | — | NH NH-Amundi | 0,00 | Hälsovård | | 2024-11-26 | 14 892,57 | 5,00 | 44,18 |
| Aktier | 14,21 Mrd | — | KO KoAct | 0,50 | Hälsovård | | 2025-11-11 | 10 338,06 | 5,59 | 22,65 |
| Aktier | 12,6 Mrd | — | KR KB RISE | 0,00 | Hälsovård | FnGuide HealthCare Index - KRW - Benchmark TR Net | 2016-09-23 | 16 773,64 | 4,73 | 37,18 |
IS | Aktier | 10,79 Mrd | 1,68 M | IS iShares | 0,44 | Hälsovård | NYSE Biotechnology (TR) | 2001-02-05 | 203,66 | 5,10 | 21,90 |
SP | Aktier | 9,64 Mrd | 8,85 M | SP SPDR | 0,35 | Hälsovård | S&P Biotechnology Select Industry | 2006-01-31 | 144,08 | 5,08 | 0,00 |
| Aktier | 9,16 Mrd | — | AC ACE | 0,30 | Hälsovård | Solactive Global Big Pharma Index - Benchmark Price Return | 2024-11-19 | 12 860,55 | 7,21 | 21,79 |
KI | Aktier | 8,41 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 2024-05-28 | 12 779,55 | 0,00 | 0,00 |
| Aktier | 8,18 Mrd | — | AC ACE | 0,45 | Hälsovård | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 2024-11-19 | 12 381,65 | 3,60 | 21,75 |
| Aktier | 7,94 Mrd | — | KO KoAct | 0,00 | Hälsovård | | 2026-01-27 | 10 133,67 | 4,34 | 29,64 |
| Aktier | 6,85 Mrd | — | KO KoAct | 0,50 | Hälsovård | | 2024-09-03 | 12 841,88 | 4,21 | 17,95 |
BO | Aktier | 6,66 Mrd | — | BO Bosera | 0,65 | Hälsovård | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 2021-03-18 | 0,61 | 2,75 | 12,80 |
CH | Aktier | 6,37 Mrd | — | CH ChinaAMC | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-09-29 | 0,82 | 3,00 | 21,32 |
KI | Aktier | 5,93 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 2024-05-28 | 11 652,44 | 4,37 | 17,87 |
| Aktier | 5,69 Mrd | — | MA Maxwealth | 0,60 | Hälsovård | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 2021-04-22 | 0,49 | 2,64 | 31,06 |
| Aktier | 5,44 Mrd | — | NI Nippon | 0,19 | Hälsovård | Nifty Pharma Index - INR - Benchmark TR Gross | 2021-07-02 | 17,49 | 4,59 | 31,47 |
NF | Aktier | 5,44 Mrd | — | NF NEXT FUNDS | 0,32 | Hälsovård | | 2008-03-21 | 33 088,93 | 1,86 | 21,64 |
| Aktier | 5,15 Mrd | — | KR KB RISE | 0,35 | Hälsovård | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 2024-02-27 | 9 602,93 | 7,72 | 19,09 |
TE | Aktier | 4,91 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | TOPIX-17 PHARMACEUTICAL - JPY | 2016-06-29 | 12 065,00 | 0,00 | 0,00 |
IN | Aktier | 4,86 Mrd | — | IN Invesco | 0,00 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-10-16 | 1,69 | 3,45 | 24,62 |
IC | Aktier | 4,74 Mrd | — | IC ICBC | 0,00 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-26 | 1,24 | 0,00 | 0,00 |
TE | Aktier | 4,59 Mrd | — | TE Tiger ETF | 0,50 | Hälsovård | FnGuide Medical Device Index - KRX - Benchmark TR Net | 2018-11-08 | 10 208,68 | 2,77 | 23,45 |
IS | Aktier | 4,55 Mrd | 866 097 | IS iShares | 0,37 | Hälsovård | Russell 1000 Health Care RIC 22.5/45 Capped Index | 2000-06-12 | 74,31 | 4,86 | 22,76 |
IS | Aktier | 4,49 Mrd | 222 416 | IS iShares | 0,38 | Hälsovård | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 2001-11-13 | 108,53 | 4,19 | 21,81 |
EF | Aktier | 4,02 Mrd | — | EF E Fund | 0,00 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-18 | 1,18 | 0,00 | 0,00 |
FI | Aktier | 3,95 Mrd | 253 941 | FI Fidelity | 0,08 | Hälsovård | MSCI US IMI 25/50 Health Care | 2013-10-21 | 84,77 | 4,77 | 22,64 |
IS | Aktier | 3,92 Mrd | 2,84 M | IS iShares | 0,37 | Hälsovård | DJ US Select / Medical Equipment | 2006-05-01 | 56,01 | 3,79 | 29,41 |
XT | Aktier | 3,92 Mrd | 68 257 | XT Xtrackers | 0,25 | Hälsovård | MSCI World Index / Health Care -SEC | 2016-03-04 | 59,33 | 4,44 | 21,81 |
GU | Aktier | 3,73 Mrd | — | GU Guotai | 0,60 | Hälsovård | CSI Biomedical Index - CNY - Benchmark TR Gross | 2019-04-18 | 1,00 | 0,00 | 0,00 |
IS | Aktier | 3,4 Mrd | 526 753 | IS iShares | 0,15 | Hälsovård | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 2015-11-20 | 14,35 | 4,86 | 22,63 |
FU | Aktier | 3,15 Mrd | — | FU Fullgoal | 0,60 | Hälsovård | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 2023-06-14 | 1,44 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 2,93 Mrd | 75 278 | FT First Trust | 0,55 | Hälsovård | NYSE Arca Biotechnology Index | 2006-06-19 | 262,88 | 3,45 | 22,71 |
NH | Aktier | 2,73 Mrd | — | NH NH-Amundi | 0,45 | Hälsovård | iSelect K-MediTech Index - KRW - Benchmark Price Return | 2023-12-21 | 9 115,65 | 3,43 | 26,31 |
| Aktier | 2,46 Mrd | — | HW Hwabao | 0,00 | Hälsovård | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 Mrd | 0,00 | 0,00 |
| Aktier | 2,4 Mrd | — | IP ICICI Prudential IETF | 0,13 | Hälsovård | Nifty Healthcare Index - INR - Benchmark TR Gross | 2021-05-18 | 177,02 | 5,10 | 34,66 |
GU | Aktier | 2,3 Mrd | — | GU Guotai | 0,60 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2020-12-24 | 0,42 | 3,08 | 30,90 |
CH | Aktier | 2,21 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 15,76 | 3,09 | 22,35 |
CH | Aktier | 2,21 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 15,76 | 3,09 | 22,35 |
HA | Aktier | 2,08 Mrd | 330 949 | HA Harvest | 0,97 | Hälsovård | | 2014-12-18 | 7,42 | 5,01 | 23,83 |
PA | Aktier | 1,82 Mrd | — | PA Ping An | 0,60 | Hälsovård | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 2021-06-09 | 0,36 | 4,13 | 25,07 |
IS | Aktier | 1,82 Mrd | 28 027 | IS iShares | 0,41 | Hälsovård | S&P Global 1200 Healthcare Sector Index - AUD | 2001-11-13 | 160,67 | 0,00 | 0,00 |
IS | Aktier | 1,66 Mrd | 252 622 | IS iShares | 0,37 | Hälsovård | DJ US Select / Pharmaceutical | 2006-05-01 | 104,65 | 4,59 | 21,41 |
EF | Aktier | 1,62 Mrd | — | EF E Fund | 0,20 | Hälsovård | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 2022-01-19 | 1,11 | 2,50 | 20,25 |
IS | Aktier | 1,55 Mrd | 148 766 | IS iShares | 0,40 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 10,76 | 3,82 | 20,92 |
AM | Aktier | 1,49 Mrd | — | AM Amundi | 0,50 | Hälsovård | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 2022-06-08 | 9 937,75 | 2,82 | 14,76 |
XT | Aktier | 1,47 Mrd | 25 565 | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 70,78 | 5,07 | 22,81 |
EF | Aktier | 1,45 Mrd | — | EF E Fund | 0,20 | Hälsovård | China Securities Medical Index - CNY - Benchmark TR Gross | 2021-07-08 | 0,40 | 4,40 | 29,55 |
EF | Aktier | 1,44 Mrd | — | EF E Fund | 0,20 | Hälsovård | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 2021-01-14 | 0,50 | 2,80 | 29,20 |
IS | Aktier | 1,41 Mrd | 103 162 | IS iShares | 0,40 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 9,80 | 3,82 | 20,92 |
IS | Aktier | 1,39 Mrd | 777 332 | IS iShares | 0,37 | Hälsovård | DJ US Select / Health Care Providers | 2006-05-01 | 54,05 | 2,30 | 16,34 |
CA | Aktier | 1,39 Mrd | — | CA Cathay | 1,05 | Hälsovård | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 2021-11-22 | 8,22 | 3,39 | 17,66 |
PB | Aktier | 1,35 Mrd | 191 232 | PB Portfolio Building Block ETFs | 0,13 | Hälsovård | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 2025-11-24 | 29,98 | 4,93 | 20,32 |
EF | Aktier | 1,32 Mrd | — | EF E Fund | 0,20 | Hälsovård | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 2021-02-03 | 0,68 | 3,14 | 28,62 |
GU | Aktier | 1,31 Mrd | — | GU Guotai | 0,60 | Hälsovård | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 2025-08-01 | 0,95 | 0,00 | 0,00 |
IS | Aktier | 1,29 Mrd | 246 880 | IS iShares | 0,35 | Hälsovård | NASDAQ / Biotechnology | 2017-10-19 | 10,06 | 0,00 | 0,00 |
IN | Aktier | 1,21 Mrd | 295 885 | IN Invesco | 0,40 | Hälsovård | S&P 500 Equal Weighted / Health Care -SEC | 2006-11-01 | 39,10 | 3,04 | 19,91 |
HA | Aktier | 1,13 Mrd | — | HA Harvest | 0,60 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-07-30 | 0,91 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 1,12 Mrd | 56 793 | FT First Trust | 0,61 | Hälsovård | StrataQuant Health Care Index | 2007-05-08 | 130,43 | 3,02 | 17,23 |
XT | Aktier | 1,12 Mrd | 16 219 | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 54,00 | 5,07 | 22,81 |
AM | Aktier | 1,11 Mrd | 141 | AM Amundi | 0,30 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-08-19 | 628,29 | 7,37 | 31,30 |
AM | Aktier | 1,07 Mrd | 346 | AM Amundi | 0,30 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2024-03-21 | 210,98 | 2,98 | 20,61 |
AM | Aktier | 1,07 Mrd | 13 464 | AM Amundi | 0,30 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2024-03-21 | 166,16 | 2,85 | 19,76 |
FT | etf_assetclass_Sector Equity | 1,06 Mrd | 507 720 | FT First Trust | 0,60 | Hälsovård | Nasdaq US Smart Pharmaceuticals Index | 2016-09-20 | 42,08 | 4,73 | 18,68 |
VA | Aktier | 1,02 Mrd | 306 629 | VA VanEck | 0,36 | Hälsovård | MVIS US Listed Pharmaceutical 25 | 2011-12-20 | 114,96 | 4,92 | 18,95 |
AM | Aktier | 1,01 Mrd | 937 | AM Amundi | 0,30 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-08-19 | 572,14 | 7,68 | 29,88 |
GX | Aktier | 977,46 M | — | GX Global X | 0,59 | Hälsovård | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 2021-06-21 | 1 739,46 | 1,90 | 19,17 |
CS | Aktier | 926,44 M | — | CS CSOP | 1,50 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-07-21 | 3,75 | 3,33 | 23,96 |
| Aktier | 897,71 M | — | WA Wanjia | 0,00 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-09-13 | 1,62 | 3,45 | 24,62 |
AM | Aktier | 894 M | 1 276 | AM Amundi | 0,30 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2024-03-21 | 139,10 | 2,85 | 19,76 |
IS | Aktier | 811,09 M | 59 594 | IS iShares | 0,18 | Hälsovård | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 2019-10-17 | 7,88 | 4,16 | 22,04 |
| Aktier | 800,1 M | — | AB Aditya Birla Sun Life | 0,09 | Hälsovård | Nifty Healthcare Index - INR - Benchmark TR Gross | 2021-10-19 | 17,74 | 5,10 | 34,66 |
IS | Aktier | 777,48 M | 99 107 | IS iShares | 0,18 | Hälsovård | MSCI Europe Health Care 20/35 Capped Index - EUR | 2020-11-17 | 6,56 | 3,73 | 19,22 |
SP | Aktier | 776,13 M | 10 814 | SP SPDR | 0,30 | Hälsovård | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 2009-02-28 | 75,15 | 4,44 | 21,81 |
CA | Aktier | 721,53 M | — | CA Cathay | 0,41 | Hälsovård | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 2019-04-23 | 30,05 | 0,00 | 0,00 |
IS | Aktier | 703,9 M | 8 742 | IS iShares | 0,46 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2001-04-25 | 122,96 | 3,63 | 19,15 |
GX | Aktier | 635,16 M | — | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-24 | 67,93 | 4,18 | 30,21 |
IN | Aktier | 632,2 M | 26 003 | IN Invesco | 0,40 | Hälsovård | NASDAQ / Biotechnology | 2014-11-06 | 71,88 | 4,94 | 21,49 |
SP | Aktier | 624,91 M | 1 722 | SP SPDR | 0,18 | Hälsovård | MSCI Europe Health Care Index - EUR | 2001-09-30 | 248,96 | 3,73 | 19,22 |
IS | Aktier | 622,03 M | 10 244 | IS iShares | 0,66 | Hälsovård | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 2011-04-12 | 80,00 | 0,00 | 0,00 |
GX | Aktier | 621,89 M | 19 470 | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-24 | 66,51 | 4,18 | 30,21 |
CS | Aktier | 615,18 M | — | CS China Southern | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 2022-06-17 | 1,10 | 2,98 | 21,35 |
IN | Aktier | 614,66 M | 1 344 | IN Invesco | 0,14 | Hälsovård | S&P Select Sector Capped 20% Health Care Index | 2009-12-16 | 883,17 | 5,12 | 22,97 |